A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

NCT05620160 ·Status: COMPLETED ·Phase: PHASE3

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

NCT05387369 ·Status: RECRUITING

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

NCT04523181 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

NCT05305547 ·Status: COMPLETED ·Phase: PHASE3

A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19

NCT05713318 ·Status: COMPLETED ·Phase: PHASE2

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

NCT05787418 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19

NCT04343651 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

NCT05947812 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

NCT06063330 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19

NCT06039163 ·Status: COMPLETED ·Phase: PHASE1

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

NCT05715528 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

NCT05745545 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of ES16001 in Patients With COVID-19

NCT05525182 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

NCT05897541 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

NCT05667714 ·Status: UNKNOWN ·Phase: NA

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

NCT05752175 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

NCT05702489 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection

NCT05507489 ·Status: UNKNOWN ·Phase: NA

A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2

NCT05765279 ·Status: COMPLETED ·Phase: NA

A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients

NCT04869228 ·Status: TERMINATED ·Phase: PHASE3

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

NCT05157269 ·Status: WITHDRAWN ·Phase: PHASE3

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

NCT04713176 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.

NCT05007236 ·Status: COMPLETED ·Phase: PHASE2

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

NCT04593641 ·Status: COMPLETED ·Phase: PHASE1